Navigation Links
First Telescopic Implant in Connecticut for Macular Degeneration

CHESHIRE, Conn., March 7, 2013 /PRNewswire-iReach/ -- Dr. Randolph Kinkade has been recently interviewed on WFSB's Your Health and WTNH's Health News discussing this new technology.  Dr. Kinkade, a Connecticut optometrist, is a founding member of the International Academy of Low Vision Specialists. 

About the size of an eraser tip, the Implantable Miniature Telescope shows promise for some patients who are legal blind due to macular degeneration.  Macular degeneration is the leading cause of permanent vision loss in older Americans. 

"I have been fitting Spectacle Miniature Telescopes in glasses for improving eyesight for over twenty years to help patients improve their ability to read, write and watch television", says Dr. Kinkade. "For certain patients we now have the ability to replace a developing cataract in their eye with a micro-telescope that returns some very useful vision."

The newly FDA and Medicare approved telescope is placed in only one eye.  The telescope implant focuses and enlarged image onto healthier parts of the macula and retina at the back of the eye.  The other eye provides the necessary peripheral or side vision for walking and performing other tasks.

Dr. Kinkade's treatment role is with candidate selection and determining which eye gets the implant.  He also spends considerable time with patients after surgery guiding them to use their new vision.  Dr. Mark Milner will be doing the surgery.

"The implant is not a cure for macular degeneration, but a rehabilitation tool to return some very important vision", says Dr. Kinkade.  "Patients will need to relearn to see and use additional low vision aids to maximize their vision."

For pictures of the telescopic implant, educational videos and information about the treatment program please visit

Dr. Kinkade office telephone is (800) 756-0766 and he can be emailed at

About Macular Degeneration

  • Macular degeneration affects the macula, the part of the retina needed for detail central vision. Patients do see things to the side with their peripheral vision, but it is too blurry for detailed vision like reading.
  • The first signs of macular degeneration may include wavy lines, distortion, or blurry spots when reading.
  • There are two types of macular degeneration (wet and dry).  There is no medical treatment for the dry form of the disease.
  • Low vision rehabilitation provides Spectacle Miniature Telescopes and other magnification aids to help restore lost vision.

Media Contact: Randolph Kinkade , OD, MPH, Low Vision Consulting, (800) 756-0766,

News distributed by PR Newswire iReach:

SOURCE Low Vision Consulting
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Thoratec Schedules First Quarter Conference Call, Webcast
3. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
4. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
5. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
6. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
7. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
8. Insmed to Host 2012 First Quarter Earnings Conference Call
9. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
10. Henry Schein to Webcast First Quarter 2012 Conference Call Tuesday, May 8, at 10:00 a.m. EDT
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association ... it will receive two significant new grants to support its work to advance ... 25th anniversary by recognizing patients, medical professionals and scientists for their work in ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
Breaking Medicine News(10 mins):